IMP
Process View
response to gamma radiation
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to gamma radiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CRYAB | crystallin, alpha B | 0.927 | ||
| BRCA1 | breast cancer 1, early onset | 0.893 | ||
| NBN | nibrin | 0.861 | ||
| RING1 | ring finger protein 1 | 0.856 | ||
| IL8 | interleukin 8 | 0.837 | ||
| HDAC1 | histone deacetylase 1 | 0.821 | Fly | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.799 | Rat | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.735 | Rat | |
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.703 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.696 | ||
| BCL2L1 | BCL2-like 1 | 0.684 | Mouse | |
| APLF | aprataxin and PNKP like factor | 0.560 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.537 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.525 | ||
| HSPB8 | heat shock 22kDa protein 8 | 0.503 | Human | |
| CRYBB2 | crystallin, beta B2 | 0.483 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.475 | ||
| PARP1 | poly (ADP-ribose) polymerase 1 | 0.448 | ||
| TP53 | tumor protein p53 | 0.442 | ||
| USP11 | ubiquitin specific peptidase 11 | 0.429 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.389 | Rat | |
| HSPB1 | heat shock 27kDa protein 1 | 0.377 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.366 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.357 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.337 | ||
| RNF2 | ring finger protein 2 | 0.324 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.313 | ||
| IL1B | interleukin 1, beta | 0.289 | Rat | |
| PCGF3 | polycomb group ring finger 3 | 0.286 | ||
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.261 | Mouse | |
| BMI1 | BMI1 polycomb ring finger oncogene | 0.247 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.236 | ||
| PCGF2 | polycomb group ring finger 2 | 0.226 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.170 | ||
| SIRT1 | sirtuin 1 | 0.168 | ||
| TRIM63 | tripartite motif containing 63 | 0.165 | Human | |
| EP300 | E1A binding protein p300 | 0.156 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.153 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.148 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.140 | Mouse | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.127 | ||
| H2AFX | H2A histone family, member X | 0.113 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.108 | Mouse | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.088 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.085 | ||
| GFM1 | G elongation factor, mitochondrial 1 | 0.079 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.074 | ||
| RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.072 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.072 | ||
| APTX | aprataxin | 0.070 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.063 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.062 | ||
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.055 | ||
| HDAC2 | histone deacetylase 2 | 0.053 | Fly | |
| WWOX | WW domain containing oxidoreductase | 0.053 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.051 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.050 | ||
| HSPB2 | heat shock 27kDa protein 2 | 0.050 | Human | |
| PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.047 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.046 | ||
| BLM | Bloom syndrome, RecQ helicase-like | 0.046 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.036 | ||
| XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 | 0.036 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.036 | ||
| PCGF1 | polycomb group ring finger 1 | 0.035 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.034 | Rat | |
| CBX6 | chromobox homolog 6 | 0.034 | Fly | |
| STK4 | serine/threonine kinase 4 | 0.031 | ||
| BCL2A1 | BCL2-related protein A1 | 0.030 | ||
| AMOTL1 | angiomotin like 1 | 0.029 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.028 | ||
| STK3 | serine/threonine kinase 3 | 0.028 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.028 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.027 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.027 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.026 | Rat | |
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.024 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.024 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.024 | ||
| PCGF5 | polycomb group ring finger 5 | 0.023 | ||
| BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.023 | ||
| HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.022 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.022 | ||
| UBE3A | ubiquitin protein ligase E3A | 0.020 | ||
| FANCE | Fanconi anemia, complementation group E | 0.019 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.019 | ||
| RNR2 | l-rRNA | 0.017 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.017 | ||
| BID | BH3 interacting domain death agonist | 0.017 | ||
| ARIH2 | ariadne homolog 2 (Drosophila) | 0.016 | ||
| KRT5 | keratin 5 | 0.016 | ||
| EGR2 | early growth response 2 | 0.016 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.016 | ||
| MRPL38 | mitochondrial ribosomal protein L38 | 0.016 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.016 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.016 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.016 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.016 | ||
| MAP1S | microtubule-associated protein 1S | 0.015 | ||
| ATM | ataxia telangiectasia mutated | 0.015 | ||
| SMC1A | structural maintenance of chromosomes 1A | 0.015 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.014 | ||
| BRCA2 | breast cancer 2, early onset | 0.014 | Mouse | |
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.014 | ||
| RASSF3 | Ras association (RalGDS/AF-6) domain family member 3 | 0.014 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.014 | ||
| TTI1 | Tel2 interacting protein 1 homolog (S. pombe) | 0.014 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.014 | ||
| CRYGC | crystallin, gamma C | 0.014 | ||
| RPL39 | ribosomal protein L39 | 0.014 | ||
| TRPS1 | trichorhinophalangeal syndrome I | 0.014 | ||
| PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | 0.014 | ||
| DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.013 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.013 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.013 | ||
| CBX8 | chromobox homolog 8 | 0.013 | Fly | |
| PML | promyelocytic leukemia | 0.013 | Mouse | |
| HDAC4 | histone deacetylase 4 | 0.013 | ||
| MUS81 | MUS81 endonuclease homolog (S. cerevisiae) | 0.013 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.013 | ||
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.012 | ||
| TERF2 | telomeric repeat binding factor 2 | 0.012 | ||
| ASF1A | ASF1 anti-silencing function 1 homolog A (S. cerevisiae) | 0.012 | ||
| PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0.012 | ||
| CBX4 | chromobox homolog 4 | 0.012 | Fly | |
| PALB2 | partner and localizer of BRCA2 | 0.012 | ||
| SATB2 | SATB homeobox 2 | 0.012 | ||
| RPA1 | replication protein A1, 70kDa | 0.012 | ||
| ATMIN | ATM interactor | 0.012 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.012 | Mouse | |
| TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 | 0.012 | ||
| YAP1 | Yes-associated protein 1 | 0.011 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.011 | ||
| CHRAC1 | chromatin accessibility complex 1 | 0.011 | ||
| TCAP | titin-cap (telethonin) | 0.011 | ||
| TAF1D | TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa | 0.011 | ||
| JUNB | jun B proto-oncogene | 0.011 | ||
| HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 0.011 | ||
| TRIM39 | tripartite motif containing 39 | 0.011 | ||
| CUL5 | cullin 5 | 0.010 | ||
| IER3 | immediate early response 3 | 0.010 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.010 |